Emma Kipps

1.5k total citations · 1 hit paper
26 papers, 693 citations indexed

About

Emma Kipps is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emma Kipps has authored 26 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Kipps's work include Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Emma Kipps is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Emma Kipps collaborates with scholars based in United Kingdom, United States and Hong Kong. Emma Kipps's co-authors include Stan B. Kaye, David S.P. Tan, Alicia Okines, Malaka Ameratunga, Juanita Lopez, Kate Young, Naureen Starling, Susana Miranda, Mateus Crespo and Martin Gore and has published in prestigious journals such as Nature reviews. Cancer, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Emma Kipps

24 papers receiving 684 citations

Hit Papers

Meeting the challenge of ascites in ovarian cancer: new a... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Kipps United Kingdom 8 292 268 198 157 125 26 693
Nana Tchabo United States 14 235 0.8× 326 1.2× 204 1.0× 190 1.2× 107 0.9× 25 744
Andrew N. Stephens Australia 17 342 1.2× 304 1.1× 339 1.7× 162 1.0× 221 1.8× 32 892
Dana M. Roque United States 20 480 1.6× 348 1.3× 266 1.3× 134 0.9× 165 1.3× 61 1.1k
Shelly Seward United States 15 390 1.3× 298 1.1× 246 1.2× 157 1.0× 59 0.5× 34 898
Natalie Y.L. Ngoi Singapore 17 506 1.7× 428 1.6× 192 1.0× 146 0.9× 131 1.0× 70 919
Satoshi Tsunetoh Japan 15 243 0.8× 280 1.0× 235 1.2× 159 1.0× 68 0.5× 32 715
Hye Sook Chon United States 16 222 0.8× 213 0.8× 211 1.1× 119 0.8× 48 0.4× 68 680
Wanja Kildal Norway 14 149 0.5× 214 0.8× 92 0.5× 149 0.9× 74 0.6× 37 625
Nicoletta Staropoli Italy 14 350 1.2× 233 0.9× 69 0.3× 111 0.7× 80 0.6× 42 617
Andrea Milani Italy 12 416 1.4× 268 1.0× 110 0.6× 123 0.8× 109 0.9× 35 765

Countries citing papers authored by Emma Kipps

Since Specialization
Citations

This map shows the geographic impact of Emma Kipps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Kipps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Kipps more than expected).

Fields of papers citing papers by Emma Kipps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Kipps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Kipps. The network helps show where Emma Kipps may publish in the future.

Co-authorship network of co-authors of Emma Kipps

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Kipps. A scholar is included among the top collaborators of Emma Kipps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Kipps. Emma Kipps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Man, Kenneth K. C., Shibani Nicum, Rowan Miller, et al.. (2024). The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer. The Oncologist. 29(11). e1532–e1539. 2 indexed citations
3.
Kipps, Emma, Kenneth K. C. Man, Rebecca Roylance, et al.. (2024). The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study. European Journal of Cancer. 210. 114301–114301. 4 indexed citations
4.
Parton, Marina, et al.. (2024). The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer. Cancers. 16(16). 2822–2822.
5.
Jm, Murphy, Jacqueline Cumming, Amanda Edmondson, et al.. (2024). Implementation of a geriatric oncology service at the Royal Marsden Hospital. Journal of Geriatric Oncology. 15(2). 101698–101698. 6 indexed citations
6.
Monje‐Garcia, Laura, Emma Kipps, Angela F. Brady, et al.. (2023). From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: The RM Partners quality improvement project. Colorectal Disease. 25(9). 1844–1851. 4 indexed citations
7.
Kipps, Emma, Kenneth K. C. Man, Martin Förster, et al.. (2023). 250P The impact of inter-cycle treatment delays on progression-free survival in early stage breast cancer. Annals of Oncology. 34. S283–S283. 3 indexed citations
8.
Okines, Alicia, Kabir Mohammed, Alistair Ring, et al.. (2022). Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance. Clinical Breast Cancer. 22(7). e825–e831. 3 indexed citations
9.
Shepherd, Scott T.C., Kabir Mohammed, Karla A. Lee, et al.. (2022). Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Breast Cancer Research and Treatment. 195(3). 333–340. 5 indexed citations
10.
Förster, Martin, et al.. (2022). Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy. ESMO Open. 8(1). 100743–100743. 5 indexed citations
11.
Okines, Alicia, Emma Kipps, Maria Coakley, et al.. (2021). Impact of timing of adjuvant chemotherapy for early breast cancer: the Royal Marsden Hospital experience. British Journal of Cancer. 125(2). 299–304. 5 indexed citations
12.
Tilney, Henry S., Shaman Jhanji, Pascale Gruber, et al.. (2021). The ‘hub and spoke model’ for the management of surgical patients during the COVID‐19 pandemic. The International Journal of Health Planning and Management. 36(5). 1397–1406. 6 indexed citations
13.
Okines, Alicia, Emma Kipps, Maria Coakley, et al.. (2019). Impact of delayed adjuvant chemotherapy: The Royal Marsden Hospital (RMH) experience. Annals of Oncology. 30. iii28–iii28. 1 indexed citations
14.
Jani, Yogini, et al.. (2019). Patient factors and their impact on neutropenic events: a systematic review and meta-analysis. Supportive Care in Cancer. 27(7). 2413–2424. 14 indexed citations
15.
Kipps, Emma, Kate Young, & Naureen Starling. (2017). Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy. Therapeutic Advances in Medical Oncology. 9(3). 159–170. 26 indexed citations
16.
Kipps, Emma, David S.P. Tan, & Stan B. Kaye. (2013). Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nature reviews. Cancer. 13(4). 273–282. 416 indexed citations breakdown →
17.
Carden, Craig P., Adam Stewart, Emma Kipps, et al.. (2012). The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer. Molecular Cancer Therapeutics. 11(7). 1609–1617. 81 indexed citations
19.
Han, Liz Y., Emma Kipps, & Stan B. Kaye. (2010). Current treatment and clinical trials in ovarian cancer. Expert Opinion on Investigational Drugs. 19(4). 521–534. 13 indexed citations
20.
Larkin, James, Emma Kipps, Ceri Powell, & Charles Swanton. (2009). Review: Systemic therapy for advanced renal cell carcinoma. Therapeutic Advances in Medical Oncology. 1(1). 15–27. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026